Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
36 Cards in this Set
- Front
- Back
cytokines made by Th1 cells and fxns?
|
IFN-γ, IL-2, TNF-β
activate macrophages, CTLs, and NK cells |
|
Cytokines released by Th2 cells and fxns?
|
IL-4, IL-5, IL-6
induce B-cell proliferation and differentiation into memory B cells and plasma cells |
|
cytokine produced by activated Th (undifferentiated) cells and fxn?
|
IL-2
causes proliferation and activation of Th1 and Th2 cells |
|
MOA cyclosporine
|
binds cyclophilin, which inhibits calcineurin (involved in cytokine production by activated Tcells)
|
|
MOA tacrolimus
|
binds FK-binding protein, which inhibits calcineurin (involved in cytokine production by activated Tcells)
|
|
MOA sirolimus?
|
binds FK-binding protein and inhibits RESPONSE of T cells to cytokine w/o affecting production
|
|
immunosuppressive agents used in solid organ txp
|
cyclosporine, tacrolimus, sirolimus
|
|
immunosuppressive agent used for stem cell txp
|
tacro
|
|
immunosuppressive agents used in GVH dz
|
tacro, cyclo
|
|
other than txp, what diseases are cyclo, tacro, and siro used for?
|
RA, uveitis, psoriasis, asthma, DM type 1
|
|
d/t erratic bioavailability, monitor blood levels of this immunosuppressant
|
cyclosporine
|
|
common toxicities of cyclo & tacro?
|
renal dysfxn, HTN, neurotoxic; hyperglycemia, hyperlipidemia, cholelithiasis
|
|
siro may cause these side effects more than cyclo and tacro
|
elevated trigs, hepatotoxicity, diarrhea, myelosuppression
|
|
drug that suppresses B and T-cell activation by inhibiting inosine monophosphate dehydrogenase
|
mycophenolate mofetil
|
|
concomitant administration of allopurinol can lead to toxic effects of this immunosuppressant
|
azathioprine
|
|
prodrug whose metabolite is cytotoxic in early phases of lymphoid cell proliferation (T cells > B cells)
|
azathioprine
(metabolized to mercaptopurine) |
|
the use of azathioprine is associated with what major toxic effects?
|
BMS, increased incidence of cancer
|
|
prodrug whose metabolite is an alkylating agent that is toxic to proliferating lymphoid cells (B cells > T cells)
|
Cyclophosphamide
|
|
cytotoxic drugs sometimes used as immunosuppressants (5)
|
cyclophosphamide, cytarabine, dactinomycin, methotrexate, vincristine
|
|
MOA etanercept?
|
recombinant form of TNF receptor that sequesters TNFα (proinflammatory)
|
|
TNF inhibitor used for RA and psoriatic arthritis?
|
etanercept
|
|
monoclonal antibodies that block actions of TNFα
|
infliximab, adalimumab
|
|
drug used in RA that inhibits pyrimidine synthesis and arrests lymphocytes in G1 phase?
|
leflunomide
|
|
sedative drug that is severely teratogenic that also inhibits TNF synthesis, increases IL-10, reduces neutrophil phagocytosis, alters adhesion molecules, and enhances cell mediated immunity?
|
Thalidomide
|
|
inhibitor of T-cell activation by blocking CD2 receptor using engineered lymphocyte-associated antigen-3 (LFA-3); used in tx of psoriasis?
|
aLeFAcept
|
|
antibodies that block cellular immunity but not antibody formation; used before BMTxp to prevent GVH rxn?
|
Antilymphocyte globulin (ALG)
Antithymocyte globulin (ATG) |
|
what type of pt would warrant tx with IgG against red cell transmembrane proteins?
|
Rho(D)-negative mothers birthing a Rho(D)-positive baby to prevent Rh hemolytic dz of the newborn
(Rho-GAM) |
|
monoclonal Ab that binds CD3 antigen on T cells to block killing action; used for renal txp rejection?
|
muromonab-CD3
|
|
first dose effects of muromonab?
|
fever, chills, dyspnea, pulm edema
|
|
monoclonal Ab that binds IL-2 receptor on T cells to prevent activation; has no clinically proven side effects
|
daclizumab
|
|
monoclonal Ab used in tx-resistant Crohn's dz, RA, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis
|
Infliximab
|
|
recombinant lymphokine that promotes production of CTLs and activates NK cells, used for renal cell carcinoma and malignant melanoma?
|
Aldesleukin (IL-2)
|
|
endogenous cytokine used to decrease incidence & severity of infxns in pts w/ chronic granulomatous dz
|
IFN-λ-1b
|
|
endogenous cytokine used in tx of relapsing MS?
|
IFN-β-1b
|
|
cytokine that inhibits cell proliferation and is used in hairy cell leukemia, CML, melanoma, Kaposi sarcoma and hep B/C?
|
IFN-α-2a
|
|
clinical use of BCG?
|
immunization against Tb, immunostimulant in tx of superficial bladder cancer
|